We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Global Metabolomics Market Report 2013 - Forecasts to 2017
News

Global Metabolomics Market Report 2013 - Forecasts to 2017

Global Metabolomics Market Report 2013 - Forecasts to 2017
News

Global Metabolomics Market Report 2013 - Forecasts to 2017

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Global Metabolomics Market Report 2013 - Forecasts to 2017"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Research and Markets has announced the addition of the "Global Metabolomics Market Report 2013 - Forecasts to 2017" report to their offering.

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.

Metabolomics Market - Analysis of Global Technology, Application Trends and Landscape 2012-2017 report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as, (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept to drive R&D activity within the industry, (ii) rapid growth of metabolomics data analysis softwares and solutions, and (iii) the advancement of analytical technologies. Metabolomics is used in the identification of new biomarkers, which indicate a change in the physiological state of a cell or tissue. Biomarker screening is important in the process of new drug discovery, and is also a key in vitro diagnostics tool. Additionally it is also being used for environmental toxicology screening. While, there are major concerns of this market such as the validation challenges, the positive aspects may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: Metabolon Inc (U.S.), Metanomics (Germany), Metabolomic Technologies Inc. (U.S.), Human Metabolome Technologies (Japan), Beckman Coulter(U.S.), Agilent Technologies Inc (U.S.), Bruker Corporation (U.S.), Waters Corporation (U.S.), Biocrates Lifesciences (Austria), Chenomx Inc (Canada), Eisai co. ltd (Japan), Nextgen Metabolomics (U.S.), Phenomenome Discoveries Inc. (Canada) and Metabolomic Discoveries (Germany).

Key Topics Covered:

1. Introduction
2. Executive Summary
3. Metabolomics -Technology Landscape Analysis
4. Metabolomics - Market Landscape Analysis
5. Metabolomics - Technology Investment Potential
6. Metabolomics - Geographical Analysis
7. Competitive Landscape Analysis
8. Patent Analysis
9. Technology Analysis (Using Multi Criteria Decision Making) & Road Mapping
10 Analyst Insights & Recommendations
11 Company Profiles

Companies Mentioned:

Ab Sciex
Accelrys
Agilent Technologies
Astrazeneca Plc
Bio-Rad Laboratories
Biocrates Life Sciences Ag
Bruker Corporation
Chenomx
Eisai Co. Ltd.
Human Metabolome Technologies
Metabolomic Technologies
Metabolomx
Metabolon
Metanomics Gmbh
Nextgen Metabolomics
Phenomenome
Research Institute Of Chromatography
Shimadzu Corporation
Sidmap, Llc
Stemina Biomarker
Waters Corporation

Advertisement